Brett Guthrie

Speaker Pelosi's bill brings us one step closer to single-payer healthcare systems.

H.R. 19, the Lower Costs, More Cures Act, that I helped introduce would lower prescription drug costs while protecting innovation for new cures.

There is room for bipartisan action to lower costs.

Thanks to President Trump, America took a very different approach than our European allies.

I challenge my colleagues: Would you still agree with this statement, knowing that one of those forfeitures could have been the COVID-19 vaccine?

Under H.R. 3, we would be forced to sacrifice this access for bureaucracy and fewer cures.

I believe single-payer systems are a very dangerous idea.

We know the American people want lower prices. But they do not want to sacrifice access to life-changing treatment.

I am very concerned about the consequences of Speaker Pelosi's partisan drug bill, H.R. 3, that is before us today.

We must help patients receive proper treatments and learn ways to resolve these symptoms.

We still have many unanswered questions.

I want to help get people back to work.

Unfortunately, over 31 million Americans have tested positive for COVID-19, and some of these Americans experience symptoms weeks and months after being infected with COVID-19.

The goal of the fentanyl class scheduling is not to--not locking up low-level drug users but to stop the development of deadly fentanyl poisons at their origin, namely in drug labs overseas.

I was selling to support my habit.

I think when--somebody said it, they understand the politics and optics, and I certainly don't say there is not politics and optics in Washington, DC, but I will tell you all of us are trying to figure this out, to get it right, because it…

We just want to say we want to do research, but we don't think they are mutually exclusive.

I believe we need to ensure that the Office of National Drug Control Policy is addressing polysubstance abuse, not just opioids, but also stimulants and alcohol abuse.

Are you willing to work with me and the committee on fully evaluating current programs that are authorized or funded for substance use disorders?

When we were looking at all the CARES Act, SUPPORT Act, and all the others that we worked on, I know--and I had to change some of my attitude.

This committee has worked in a bipartisan way to authorize many programs to decrease overdose deaths.

We have had three waves of the opioid epidemic.

We must protect Americans from these harmful drugs that ruin lives and families.

It is devastating that we have lost more than 550,000 Americans due to COVID-19.

I will give unanimous consent so that we dispense of reading them all.